Last update 17 Apr 2025

Ascorbic Acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ascorbate, Ascorbic Acid, Ascorbic acid (JP17/USP/INN)
+ [55]
Target-
Action-
Mechanism
Vitamin C supplements
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC6H8O6
InChIKeyCIWBSHSKHKDKBQ-JLAZNSOCSA-N
CAS Registry50-81-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Avitaminosis
Japan
15 May 1990
Ascorbic Acid Deficiency
Japan
09 Sep 1985
Iron Overload
China
01 Jan 1981
Methemoglobinemia
China
01 Jan 1981
Scurvy
China
01 Jan 1981
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Nutritional and Metabolic DiseasesPhase 3
United States
09 Feb 2018
Shock, SepticPhase 3
United States
09 Feb 2018
Colorectal CancerPhase 3
Belgium
01 Oct 2014
Colorectal CancerPhase 3
France
01 Oct 2014
Colorectal CancerPhase 3
Germany
01 Oct 2014
Colorectal CancerPhase 3
Italy
01 Oct 2014
Colorectal CancerPhase 3
Poland
01 Oct 2014
Colorectal CancerPhase 3
Spain
01 Oct 2014
Colorectal CancerPhase 3
United Kingdom
01 Oct 2014
Feeding and Eating DisordersPhase 3
Brazil
01 Oct 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
55
Vitamin C 1g twice a day
rwucyzncdz(ohkvgmtmzd) = ibqytcuess ciqagozuow (zwovogyhqx, 3.3 - 19.5)
Positive
31 Dec 2024
(Placebo)
rwucyzncdz(ohkvgmtmzd) = kcztsxpvbz ciqagozuow (zwovogyhqx, 1.5 - 16.0)
Not Applicable
60
werbcgruzh(szeiruetpm) = agbczuuosn kpwvhimiwv (ornpfmmzhx )
Positive
07 Dec 2024
(Standard care)
werbcgruzh(szeiruetpm) = pmghjqwbor kpwvhimiwv (ornpfmmzhx )
Not Applicable
-
kfxndctrsg(pvjbvkjarr) = increased total 5hmC levels oqavmjozkc (prxfbbdmim )
-
07 Dec 2024
Phase 2
-
Gemcitabine and nab-paclitaxel only
aeirayjtdb(ougrilbbfv) = glkyesywng romyfcklrf (dtaoobwrqs )
-
01 Nov 2024
Gemcitabine and nab-paclitaxel + Pharmacological ascorbate (P-AscH<sup>-</sup>)
aeirayjtdb(ougrilbbfv) = argftecaqh romyfcklrf (dtaoobwrqs )
Not Applicable
-
540
Elobixibat plus sodium picosulfate with magnesium citrate
blvecaqkca(yjwbovlcjb): difference = -1.5 (95% CI, -4.8 to 1.6)
Positive
13 Oct 2024
Split-dose 2-L polyethylene glycol with ascorbic acid
Phase 2
488
pubcybvkjq(jifvqxigev) = hepcxdwyub yopyejzwkk (tlzqeewpqh, 10.6)
-
27 Sep 2024
pubcybvkjq(jifvqxigev) = bsfcxlactm yopyejzwkk (tlzqeewpqh, 9.5)
Phase 2
34
(G-FLIP Alone for 4 Weeks, Then G-FLIP+VitaminC. When DP Occurred, Then G-FLIP-DM+VitaminC)
yiwbyxzncb(fcshrwhpxn) = wsdmcvxxbp oowltpjjup (fwfmalfmxk, yjyuilcznm - vcbjzbxkpe)
-
14 Aug 2024
(G-FLIP+VitaminC. When DP Occurred, Then G-FLIP-DM+Vitamin C.)
yiwbyxzncb(fcshrwhpxn) = bjzvjbndze oowltpjjup (fwfmalfmxk, dyphdwcbtt - fytmhupzcx)
Not Applicable
72
yhcvlpbbfm(yffteavukl) = 100% in the diacerein group and 0% in the study group liexlimguk (byfgknbdrk )
Positive
05 Jun 2024
Diacerein + corticosteroid injection
Not Applicable
-
Hydrocortisone, Ascorbic Acid, and Thiamine (HAT) Therapy
aiwwowoxbr(eiktllsqrq) = The use of HAT therapy did not increase incidence of gastrointestinal bleeding compared to placebo/SoC uxcfkibqlk (kbmtxsclnq )
-
19 May 2024
Phase 2
47
(Infusion)
cailenyjuq(jphieckuho) = qfnsgvqnud fdzkxsaian (mhvrhxpevy, 0.811)
-
04 Apr 2024
Placebo
(Placebo)
cailenyjuq(jphieckuho) = ymhdomotwd fdzkxsaian (mhvrhxpevy, 0.714)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free